Challenges Facing the Future of Cholangiocarcinoma
Jesper Andersen, PhD
Published: Friday, May 19, 2017
Jesper Andersen, PhD, associate professor, Biotech and Innovation Centre, University of Copenhagen, discusses the challenges facing the future treatment of patients with cholangiocarcinoma.
It is difficult to do genomic stratification in this disease, as incidence is still relatively rare. Additionally, Andersen adds, it is difficult to access to good quality tissue from patients that have gone through clinical trials or genetic studies.
SELECTED LANGUAGE
Jesper Andersen, PhD, associate professor, Biotech and Innovation Centre, University of Copenhagen, discusses the challenges facing the future treatment of patients with cholangiocarcinoma.
It is difficult to do genomic stratification in this disease, as incidence is still relatively rare. Additionally, Andersen adds, it is difficult to access to good quality tissue from patients that have gone through clinical trials or genetic studies.